Author

O. Kilic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. R. Wagner· 2 shared A. A. Almotlak· 1 shared C. Lichtenfels· 1 shared J. M. Siegfried· 1 shared J. Petersburg· 1 shared L. Rozumalski· 1 shared M. Distefano· 1 shared M. R. Matos de Souza· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

C. R. Wagner

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Macro-Chemical Biology: Engineering Biomimetic Trogocytosis with Farnesylated Chemically Self-Assembled Nanorings

Y. Wang, L. Rozumalski, C. Lichtenfels, J. Petersburg, O. Kilic, M. Distefano, C. R. Wagner

This paper introduces a biomimetic trogocytosis platform using farnesylated chemically self-assembled nanorings to enable directional cargo transfer between cells.

bioRxiv · Mar 1, 2022 · PreprintBioengineering

Anti-EGFR Fibronectin Bispecific Chemically Self-Assembling Nanorings (CSANs) Induce Potent T cell Mediated Anti-Tumor Response and Downregulation of EGFR Signaling and PD-1/PD-L1 Expression

O. Kilic, M. R. Matos de Souza, A. A. Almotlak, J. M. Siegfried, C. R. Wagner

This paper demonstrates that EGFR-targeting fibronectin-based PARs suppress tumor growth in vivo by modulating the tumor microenvironment and reducing PD-1/PD-L1 expression.

bioRxiv · Apr 22, 2020Bioengineering